IncFact
Company Profiles: Revenue, Growth, Competition

VIACYTE Revenue, Growth & Competitor Profile

Last updated:

Company Awards

Brain Power (IP)
Patent/Trademark IP
 
VC / Private Equity
Venture Capital / Private Equity

Company Profile & Annual Report for Viacyte

Access the complete profile.

Viacyte Fast Facts

Revenue$10 - $50 million    See Exact Annual Revenue
EmployeesN/AExact Company Size
Primary Industry5417 Scientific Research & Development Services
Address3550 General Atomics Ct.
#2-503
San Diego, CA 92121

www.viacyte.com
Note: Revenues for privately held companies are statistical evaluations.


Viacyte's annual revenues are $10-$50 million (see exact revenue data). It is classified as operating in the Scientific Research & Development Services industry.


Viacyte's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Viacyte Annual Revenue and Growth Rate

Viacyte Revenue Est.
($ Million)
Growth Rate (%)# Employees
2016 Details in Premium Report
2015
2014
2013
2012


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Viacyte's revenues are gauged from an analysis of company filings.



Investor Activity

Viacyte has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
December 3, 2018 9 40%$90 MM
Complete list of funding rounds and total amounts in the Company Report




Viacyte's Income Statement (based on Industry Averages)

$ Millions
(Industry Average)
Viacyte Revenue (Sales) Viacyte Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that Viacyte is developing and marketing. Viacyte doesn't have any recent trademark applications, indicating Viacyte is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
REGENERATING HEALTH
Cells for scientific, laboratory or medical research
09/19/2013
ENCAPTRA
Drug delivery systems
04/22/2010
VIACYTE
Scientific research and development for medical and pharmaceutical purposes; scientific research and development related to human diseases and disorders
02/12/2010

See all trademarks and details in the Full Report.


Patent Applications

Patent applications show Viacyte's intellectual property, its current capabilities and future direction. Viacyte has applied for 48 patents since 2009. Viacyte's most recent patent was filed in November 2018 for Cell Compositions Derived From Dedifferentiated Reprogrammed Cells. Disclosed herein are cell culture compositions, for example, pancreatic cell culture compositions, derived from dedifferentiated human reprogrammed pluripotent stem cells, such as induced pluripotent stem (iPS) cells, and methods for producing and using such cell culture compositions.


Patent Application Date
Complete list of patent applications




Recession Risk

Determine whether Viacyte grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Viacyte is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



Market Share of Competition: Viacyte vs. Largest Competitors

A competitive analysis shows these companies are in the same general field as Viacyte, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
QUINTILESDurham, NC100 
SYNEOS HEALTHRaleigh, NC53 
ALEXION PHARMACEUTICALSNew Haven, CT47 
LEIDOS HOLDINGSReston, VA42 
CEPHALONFrazer, PA37 
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIAAlbuquerque, NM34 




Nearby Competitors

These companies are similar in business line and location to Viacyte. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
ILLUMINASan Diego, CA100 
ATHEROS COMMUNICATIONSSan Diego, CA40 
SANTARUSSan Diego, CA13 
NEUROCRINE BIOSCIENCESSan Diego, CA11 
ACADIA PHARMACEUTICALSSan Diego, CA8 
RETROPHINSan Diego, CA6 




Similar Sized Companies near San Diego

These are similar in size and location to Viacyte.

Company HeadquartersRevenue ($ MM)
LAK ADVERTISINGSan Diego, CA99 
1MORE USASan Diego, CA99 
HYPERION CONSTRUCTION & MAINSan Diego, CA99 
COGNITIVE MEDICAL SYSTEMSSan Diego, CA100 
COMANCHE HILLS APARTMENTSSan Diego, CA100 
SADIE ROSE BAKINGSan Diego, CA100 
ACCREDITED DEBT RELIEFSan Diego, CA99 
AD-JUSTERSan Diego, CA99 
MILLER MARINESan Diego, CA99 
EDUCACION SIGNIFICATIVASan Diego, CA98 
LEASELABSSan Diego, CA98 
ENVIRONMENTAL SPRAY SYSTEMSSan Diego, CA98 




Fastest Growing Competitors

These companies are in the same general field as Viacyte and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Viacyte Competitors